Prevalent tuberculosis and mortality among HAART initiators

Daniel Westreich, Matthew P. Fox, Annelies Van Rie and Mhairi Maskew

AIDS 2012. 2012 Jul; 26(6):770-773.

Reply to Letter Regarding Validation Study of the Child Status Index: Do Not Shoot the Messenger

Lora Sabin, Maxton Tsoka, Mohamad I. Brooks, Jonathon Simon, Candace Miller

Journal of Acquired Immunity Deficiency Syndromes. 2012 Jun; 60(2):e69-e71.

Defining efficacy and safety of meningococcal vaccines

Keiser PB, Gill CJ

Clinical Investigations. 2012 Jun; 2(6):603-614.

Scaling up Xpert MTB⁄RIF technology: the costs of laboratory vs. clinic-based roll-out in South Africa

Kathryn Schnippel, Gesine Meyer-Rath, Lawrence Long, William MacLeod, Ian Sanne, Wendy S. Stevens and Sydney Rosen

Tropical Medicine and International Health. 2012 Jun; 00(00):1-10.

Perceptions of per diems in the health sector: evidence and implications

Taryn Vian, Candace Miller, Zione Themba and Paul Bukuluki

Health Policy & Planning. 2012 Jun; 1-10.

Policies to promote use of generic medicines in low and middle income countries: A review of published literature, 2000–2010

Warren A. Kaplan, Lindsay Sarah Ritz, Marie Vitello, & Veronika J. Wirtz

Health Policy. 2012 Jun; 1-14.

Treatment outcomes after 7 years of public-sector HIV treatment

Matthew P. Fox, Kate Shearer, Mhairi Maskew, William Macleod, Pappie Majubae, Patrick Macphaile and Ian Sanne

AIDS 2012. 2012 Jun; 26:1823-1828.

Emergency Obstetrical and Neonatal Capacity and Health Center Access in Kalomo District, Zambia

Hamer DH, Semrau K, Everett LL, Mazimba A, Seidenberg P, Goggin C, Yeboah-Antwi K, Herlihy J, Sialubanje C, Musoktwane K, Thea D, Spear C, Grogan C, Maine D, Gopal S.

Second Global Symposium on Health Systems Research; 2012 May 1; .

The Impact and Cost of Scaling up GeneXpert MTB/RIF in South Africa

Gesine Meyer-Rath, Kathryn Schnippel, Lawrence Long, William MacLeod, Ian Sanne, Wendy Stevens, Sagie Pillay, Yogan Pillay, Sydney Rosen

PLoS ONE. 2012 May; 7(5):1-11.

Early infant diagnosis of HIV infection in Zambia through mobile phone texting of blood test results

Phil Seidenberg, Stephen Nicholson, Merrick Schaefer, Katherine Semrau, Maximillian Bweupe, Noel Masese, Rachael Bonawitz, Lastone Chitembo, Caitlin Goggin & Donald M. Thea

WHO Bulletin. 2012 May; 90(5):321-400.

Costs and Cost-Effectiveness of Training Traditional Birth Attendants to Reduce Neonatal Mortality in the Lufwanyama Neonatal Survival Study (LUNESP)

Lora L. Sabin, Anna B. Knapp, William B. MacLeod, Grace Phiri-Mazala, Joshua Kasimba, Davidson H. Hamer & Christopher J. Gill

PLoS ONE. 2012 Apr; 7(4):1-10.

How to calculate the annual costs of NGO- implemented programmes to support orphans and vulnerable children: a six-step approach

Bruce A Larson & Nancy Wambua

Journal of The International AIDS Society. 2012 Apr; 14(59):1-16.

How to Estimate the Cost of Point-of-Care CD4 Testing in Program Settings: An Example Using the Alere PimaTM Analyzer in South Africa

Bruce Larson, Kathryn Schnippel, Buyiswa Ndibongo, Lawrence Long, Matthew P. Fox, & Sydney Rosen

PLoS ONE. 2012 Apr; 7(4):1-8.

The Well Being of OVC and their Households in Four Districts of Mozambique

Godfrey Biemba, Candace Miller, Jonathon Simon, Maria Francisa Sales Lucas, Luís António Guerreiro Revés, Nair Teles, Elizabeth Henry, Jacqueline Stone, & Abanish Rizal

Washington, DC: USAID; 2012 Mar.

Effectiveness and safety of 30 mg versus 40 mg stavudine regimens: a cohort study among HIV- infected adults initiating HAART in South Africa

Mhairi Maskew, Daniel Westreich, Matthew P Fox, Thapelo Maotoe and Ian M Sanne

Journal of the International AIDS Society. 2012 Mar; 15(1).